Team Imagine's Chairman raised a drug's price that combats infections in HIV paitents by 5000%

Martin "Cerebral" Shkreli is the chairman for Team Imagine. He's had some issues with his previous company.

> In 2011, Martin Shkreli...attracted some acclaim when he started his own biotech company, Retrophin, and began pursuing therapies for rare diseases. He served at the helm of Retrophin until last fall, when the company ousted him, later alleging that he improperly passed off legal settlements with MSMB investors as consulting agreements. Now Retrophin is taking the dispute with the controversial entrepreneur a step further. > > Retrophin filed a federal lawsuit against Shkreli on Monday in New York alleging that he created the biotech and took it public solely to provide stock to MSMB investors when the hedge fund became insolvent. [Forbes]

He also is the owner of Turing Pharmaceuticals which, in August, bought up the marketing rights for Daraprim, which combats infections in HIV patients. > Daraprim fights toxoplasmosis, the second most common food-borne disease, which can easily infect people whose immune systems have been weakened by AIDS, chemotherapy or even pregnancy, according to the Centers for Disease Control. [Tech Dirt]

The company then raised the price by over 5,000%, so that one pill, which used to be around $14 is now $750. If you read through the Tech Dirt article, or the New York Times article, or any of these other articles, you'll see that this is 1) not a good thing and 2) Martin Shkerli does not seem like the type of individual that meets a number of the standards Riot holds its team or players to. I would urge you to write to Riot & Team Imagine to ask Martin Shkreli to change Turing Pharmaceuticals' price change and help those in need need of affordable healthcare.

TLDR: Guy owns Team Imagine. Guys owns drug company. Raises important drug price by $5000. Ask him not to.